Lipid metabolism

Last updated

Lipid metabolism is the synthesis and degradation of lipids in cells, involving the breakdown and storage of fats for energy and the synthesis of structural and functional lipids, such as those involved in the construction of cell membranes. In animals, these fats are obtained from food and are synthesized by the liver. [1] Lipogenesis is the process of synthesizing these fats. [2] [3] The majority of lipids found in the human body from ingesting food are triglycerides and cholesterol. [4] Other types of lipids found in the body are fatty acids and membrane lipids. Lipid metabolism is often considered the digestion and absorption process of dietary fat; however, there are two sources of fats that organisms can use to obtain energy: from consumed dietary fats and from stored fat. [5] Vertebrates (including humans) use both sources of fat to produce energy for organs such as the heart to function. [6] Since lipids are hydrophobic molecules, they need to be solubilized before their metabolism can begin. Lipid metabolism often begins with hydrolysis, [7] which occurs with the help of various enzymes in the digestive system. [2] Lipid metabolism also occurs in plants, though the processes differ in some ways when compared to animals. [8] The second step after the hydrolysis is the absorption of the fatty acids into the epithelial cells of the intestinal wall. [6] In the epithelial cells, fatty acids are packaged and transported to the rest of the body. [9]

Contents

Metabolic processes include lipid digestion, lipid absorption, lipid transportation, lipid storage, lipid catabolism, and lipid biosynthesis. Lipid catabolism is accomplished by a process known as beta oxidation which takes place in the mitochondria and peroxisome cell organelles.

Lipid digestion

Digestion is the first step to lipid metabolism, and it is the process of breaking the triglycerides down into smaller monoglyceride units with the help of lipase enzymes. Digestion of fats begin in the mouth through chemical digestion by lingual lipase. Ingested cholesterol is not broken down by the lipases and stays intact until it enters the epithelium cells of the small intestine. Lipids then continue to the stomach where chemical digestion continues by gastric lipase and mechanical digestion begins (peristalsis). The majority of lipid digestion and absorption, however, occurs once the fats reach the small intestines. Chemicals from the pancreas (pancreatic lipase family and bile salt-dependent lipase) are secreted into the small intestines to help breakdown the triglycerides, [10] along with further mechanical digestion, until they are individual fatty acid units able to be absorbed into the small intestine's epithelial cells. [11] It is the pancreatic lipase that is responsible for signalling for the hydrolysis of the triglycerides into separate free fatty acids and glycerol units.

Lipid absorption

Flowchart showing the lipid absorption process 2431 Lipid Absorption.jpg
Flowchart showing the lipid absorption process

The second step in lipid metabolism is absorption of fats. Short chain fatty acids can be absorbed in the stomach, while most absorption of fats occurs only in the small intestines. Once the triglycerides are broken down into individual fatty acids and glycerols, along with cholesterol, they will aggregate into structures called micelles. Fatty acids and monoglycerides leave the micelles and diffuse across the membrane to enter the intestinal epithelial cells. In the cytosol of epithelial cells, fatty acids and monoglycerides are recombined back into triglycerides. In the cytosol of epithelial cells, triglycerides and cholesterol are packaged into bigger particles called chylomicrons which are amphipathic structures that transport digested lipids. [9] Chylomicrons will travel through the bloodstream to enter adipose and other tissues in the body. [6] [2] [3]

Lipid transportation

Due to the hydrophobic nature of membrane lipids, triglycerides and cholesterols, they require special transport proteins known as lipoproteins. [1] The amphipathic structure of lipoproteins allows the triglycerides and cholesterol to be transported through the blood. Chylomicrons are one sub-group of lipoproteins which carry the digested lipids from small intestine to the rest of the body. The varying densities between the types of lipoproteins are characteristic to what type of fats they transport. [12] For example, very-low-density lipoproteins (VLDL) carry the triglycerides synthesized by our body and low-density lipoproteins (LDL) transport cholesterol to our peripheral tissues. [6] [1] A number of these lipoproteins are synthesized in the liver, but not all of them originate from this organ. [1]

Lipid storage

Lipids are stored in white adipose tissue as triglycerides. In a lean young adult human, the mass of triglycerides stored represents about 10–20 kilograms. Triglycerides are formed from a backbone of glycerol with three fatty acids. Free fatty acids are activated into acyl-CoA and esterified to finally reach the triglyceride droplet. Lipoprotein lipase has an important role. [13]

Lipid catabolism

Once the chylomicrons (or other lipoproteins) travel through the tissues, these particles will be broken down by lipoprotein lipase in the luminal surface of endothelial cells in capillaries to release triglycerides. [14] Triglycerides will get broken down into fatty acids and glycerol before entering cells and remaining cholesterol will again travel through the blood to the liver. [15]

Breakdown of fatty acids by beta oxidation Beta oxidation of palmitic acid.jpg
Breakdown of fatty acids by beta oxidation

In the cytosol of the cell (for example a muscle cell), the glycerol will be converted to glyceraldehyde 3-phosphate, which is an intermediate in the glycolysis, to get further oxidized and produce energy. However, the main steps of fatty acids catabolism occur in the mitochondria. [16] Long chain fatty acids (more than 14 carbon) need to be converted to fatty acyl-CoA in order to pass across the mitochondria membrane. [6] Fatty acid catabolism begins in the cytoplasm of cells as acyl-CoA synthetase uses the energy from cleavage of an ATP to catalyze the addition of coenzyme A to the fatty acid. [6] The resulting acyl-CoA cross the mitochondria membrane and enter the process of beta oxidation. The main products of the beta oxidation pathway are acetyl-CoA (which is used in the citric acid cycle to produce energy), NADH and FADH. [16] The process of beta oxidation requires the following enzymes: acyl-CoA dehydrogenase, enoyl-CoA hydratase, 3-hydroxyacyl-CoA dehydrogenase, and 3-ketoacyl-CoA thiolase. [15] The diagram to the left shows how fatty acids are converted into acetyl-CoA. The overall net reaction, using palmitoyl-CoA (16:0) as a model substrate is:

7 FAD + 7 NAD+ + 7 CoASH + 7 H2O + H(CH2CH2)7CH2CO-SCoA → 8 CH3CO-SCoA + 7 FADH2 + 7 NADH + 7 H+

Lipid biosynthesis

In addition to dietary fats, storage lipids stored in the adipose tissues are one of the main sources of energy for living organisms. [17] Triacylglycerols, lipid membrane and cholesterol can be synthesized by the organisms through various pathways.

Membrane lipid biosynthesis

There are two major classes of membrane lipids: glycerophospholipids and sphingolipids. Although many different membrane lipids are synthesized in our body, pathways share the same pattern. The first step is synthesizing the backbone (sphingosine or glycerol), the second step is the addition of fatty acids to the backbone to make phosphatidic acid. Phosphatidic acid is further modified with the attachment of different hydrophilic head groups to the backbone. Membrane lipid biosynthesis occurs in the endoplasmic reticulum membrane. [18]

Triglyceride biosynthesis

The phosphatidic acid is also a precursor for triglyceride biosynthesis. Phosphatidic acid phosphotase catalyzes the conversion of phosphatidic acid to diacylglyceride, which will be converted to triglycerides by acyltransferase. Triglyceride biosynthesis occurs in the cytosol. [19]

Fatty acid biosynthesis

The precursor for fatty acids is acetyl-CoA and it occurs in the cytosol of the cell. [19] The overall net reaction, using palmitate (16:0) as a model substrate is:

8 Acetyl-coA + 7 ATP + 14 NADPH + 6H+ → palmitate + 14 NADP+ + 6H2O + 7ADP + 7P¡

Cholesterol biosynthesis

Cholesterol can be made from acetyl-CoA through a multiple-step pathway known as isoprenoid pathway. Cholesterols are essential because they can be modified to form different hormones in the body such as progesterone. [6] 70% of cholesterol biosynthesis occurs in the cytosol of liver cells.[ citation needed ]

Hormonal regulation of lipid metabolism

Lipid metabolism is tightly regulated by hormones to ensure a balance between energy storage and utilization.

Lipid metabolism disorders

Lipid metabolism disorders (including inborn errors of lipid metabolism) are illnesses where trouble occurs in breaking down or synthesizing fats (or fat-like substances). [22] Lipid metabolism disorders are associated with an increase in the concentrations of plasma lipids in the blood such as LDL cholesterol, VLDL, and triglycerides which most commonly lead to cardiovascular diseases. [23] A good deal of the time these disorders are hereditary, meaning it's a condition that is passed along from parent to child through their genes. [22] Gaucher's disease (types I, II, and III), Niemann–Pick disease, Tay–Sachs disease, and Fabry's disease are all diseases where those afflicted can have a disorder of their body's lipid metabolism. [24] Rarer diseases concerning a disorder of the lipid metabolism are sitosterolemia, Wolman's disease, Refsum's disease, and cerebrotendinous xanthomatosis. [24]

Types of lipids

The types of lipids involved in lipid metabolism include:

Related Research Articles

<span class="mw-page-title-main">Cholesterol</span> Sterol biosynthesized by all animal cells

Cholesterol is the principal sterol of all higher animals, distributed in body tissues, especially the brain and spinal cord, and in animal fats and oils.

<span class="mw-page-title-main">Fatty acid</span> Carboxylic acid

In chemistry, particularly in biochemistry, a fatty acid is a carboxylic acid with an aliphatic chain, which is either saturated or unsaturated. Most naturally occurring fatty acids have an unbranched chain of an even number of carbon atoms, from 4 to 28. Fatty acids are a major component of the lipids in some species such as microalgae but in some other organisms are not found in their standalone form, but instead exist as three main classes of esters: triglycerides, phospholipids, and cholesteryl esters. In any of these forms, fatty acids are both important dietary sources of fuel for animals and important structural components for cells.

<span class="mw-page-title-main">Lipid</span> Substance of biological origin that is soluble in nonpolar solvents

Lipids are a broad group of organic compounds which include fats, waxes, sterols, fat-soluble vitamins, monoglycerides, diglycerides, phospholipids, and others. The functions of lipids include storing energy, signaling, and acting as structural components of cell membranes. Lipids have applications in the cosmetic and food industries, and in nanotechnology.

<span class="mw-page-title-main">Lipoprotein</span> Biochemical assembly whose purpose is to transport hydrophobic lipid molecules

A lipoprotein is a biochemical assembly whose primary function is to transport hydrophobic lipid molecules in water, as in blood plasma or other extracellular fluids. They consist of a triglyceride and cholesterol center, surrounded by a phospholipid outer shell, with the hydrophilic portions oriented outward toward the surrounding water and lipophilic portions oriented inward toward the lipid center. A special kind of protein, called apolipoprotein, is embedded in the outer shell, both stabilising the complex and giving it a functional identity that determines its role.

<span class="mw-page-title-main">Acetyl-CoA</span> Chemical compound

Acetyl-CoA is a molecule that participates in many biochemical reactions in protein, carbohydrate and lipid metabolism. Its main function is to deliver the acetyl group to the citric acid cycle to be oxidized for energy production.

<span class="mw-page-title-main">Lipolysis</span> Metabolism involving breakdown of lipids

Lipolysis is the metabolic pathway through which lipid triglycerides are hydrolyzed into a glycerol and free fatty acids. It is used to mobilize stored energy during fasting or exercise, and usually occurs in fat adipocytes. The most important regulatory hormone in lipolysis is insulin; lipolysis can only occur when insulin action falls to low levels, as occurs during fasting. Other hormones that affect lipolysis include leptin, glucagon, epinephrine, norepinephrine, growth hormone, atrial natriuretic peptide, brain natriuretic peptide, and cortisol.

<span class="mw-page-title-main">Ketogenesis</span> Chemical synthesis of ketone bodies

Ketogenesis is the biochemical process through which organisms produce ketone bodies by breaking down fatty acids and ketogenic amino acids. The process supplies energy to certain organs, particularly the brain, heart and skeletal muscle, under specific scenarios including fasting, caloric restriction, sleep, or others.

<span class="mw-page-title-main">Chylomicron</span> One of the five major groups of lipoprotein

Chylomicrons, also known as ultra low-density lipoproteins (ULDL), are lipoprotein particles that consist of triglycerides (85–92%), phospholipids (6–12%), cholesterol (1–3%), and proteins (1–2%). They transport dietary lipids, such as fats and cholesterol, from the intestines to other locations in the body, within the water-based solution of the bloodstream. ULDLs are one of the five major groups lipoproteins are divided into based on their density. A protein specific to chylomicrons is ApoB48.

<span class="mw-page-title-main">Lacteal</span> Lymphatic capillary

A lacteal is a lymphatic capillary that absorbs dietary fats in the villi of the small intestine.

<span class="mw-page-title-main">Lipoprotein lipase</span> Mammalian protein found in Homo sapiens

Lipoprotein lipase (LPL) (EC 3.1.1.34, systematic name triacylglycerol acylhydrolase (lipoprotein-dependent)) is a member of the lipase gene family, which includes pancreatic lipase, hepatic lipase, and endothelial lipase. It is a water-soluble enzyme that hydrolyzes triglycerides in lipoproteins, such as those found in chylomicrons and very low-density lipoproteins (VLDL), into two free fatty acids and one monoacylglycerol molecule:

Fatty acid metabolism consists of various metabolic processes involving or closely related to fatty acids, a family of molecules classified within the lipid macronutrient category. These processes can mainly be divided into (1) catabolic processes that generate energy and (2) anabolic processes where they serve as building blocks for other compounds.

<span class="mw-page-title-main">Glycerophospholipid</span> Class of lipids

Glycerophospholipids or phosphoglycerides are glycerol-based phospholipids. They are the main component of biological membranes in eukaryotic cells. They are a type of lipid, of which its composition affects membrane structure and properties. Two major classes are known: those for bacteria and eukaryotes and a separate family for archaea.

In biochemistry, lipogenesis is the conversion of fatty acids and glycerol into fats, or a metabolic process through which acetyl-CoA is converted to triglyceride for storage in fat. Lipogenesis encompasses both fatty acid and triglyceride synthesis, with the latter being the process by which fatty acids are esterified to glycerol before being packaged into very-low-density lipoprotein (VLDL). Fatty acids are produced in the cytoplasm of cells by repeatedly adding two-carbon units to acetyl-CoA. Triacylglycerol synthesis, on the other hand, occurs in the endoplasmic reticulum membrane of cells by bonding three fatty acid molecules to a glycerol molecule. Both processes take place mainly in liver and adipose tissue. Nevertheless, it also occurs to some extent in other tissues such as the gut and kidney. A review on lipogenesis in the brain was published in 2008 by Lopez and Vidal-Puig. After being packaged into VLDL in the liver, the resulting lipoprotein is then secreted directly into the blood for delivery to peripheral tissues.

In chemistry, de novo synthesis is the synthesis of complex molecules from simple molecules such as sugars or amino acids, as opposed to recycling after partial degradation. For example, nucleotides are not needed in the diet as they can be constructed from small precursor molecules such as formate and aspartate. Methionine, on the other hand, is needed in the diet because while it can be degraded to and then regenerated from homocysteine, it cannot be synthesized de novo.

Acid lipase disease or deficiency is a name used to describe two related disorders of fatty acid metabolism. Acid lipase disease occurs when the enzyme lysosomal acid lipase that is needed to break down certain fats that are normally digested by the body is lacking or missing. This results in the toxic buildup of these fats in the body's cells and tissues. These fatty substances, called lipids, include waxes, oils, and cholesterol.

Starvation response in animals is a set of adaptive biochemical and physiological changes, triggered by lack of food or extreme weight loss, in which the body seeks to conserve energy by reducing metabolic rate and/or non-resting energy expenditure to prolong survival and preserve body fat and lean mass.

Blood lipids are lipids in the blood, either free or bound to other molecules. They are mostly transported in a phospholipid capsule, and the type of protein embedded in this outer shell determines the fate of the particle and its influence on metabolism. Examples of these lipids include cholesterol and triglycerides. The concentration of blood lipids depends on intake and excretion from the intestine, and uptake and secretion from cells. Hyperlipidemia is the presence of elevated or abnormal levels of lipids and/or lipoproteins in the blood, and is a major risk factor for cardiovascular disease.

Glyceroneogenesis is a metabolic pathway which synthesizes glycerol 3-phosphate from precursors other than glucose. Usually, glycerol 3-phosphate is generated from glucose by glycolysis, in the liquid of the cell's cytoplasm. Glyceroneogenesis is used when the concentrations of glucose in the cytosol are low, and typically uses pyruvate as the precursor, but can also use alanine, glutamine, or any substances from the TCA cycle. The main regulator enzyme for this pathway is an enzyme called phosphoenolpyruvate carboxykinase (PEPC-K), which catalyzes the decarboxylation of oxaloacetate to phosphoenolpyruvate. Glyceroneogenesis is observed mainly in adipose tissue, and in the liver. A significant biochemical pathway regulates cytosolic lipid levels. Intense suppression of glyceroneogenesis may lead to metabolic disorders such as type 2 diabetes.

<span class="mw-page-title-main">Pirinixic acid</span> Chemical compound

Pirinixic acid is a peroxisome proliferator-activated receptor alpha (PPARα) agonist that is under experimental investigation for prevention of severe cardiac dysfunction, cardiomyopathy and heart failure as a result of lipid accumulation within cardiac myocytes. Treatment is primarily aimed at individuals with an adipose triglyceride lipase (ATGL) enzyme deficiency or mutation because of the essential PPAR protein interactions with free fatty acid monomers derived from the ATGL catalyzed lipid oxidation reaction. It was discovered as WY-14,643 in 1974.

<span class="mw-page-title-main">Diglyceride</span> Type of fat derived from glycerol and two fatty acids

A diglyceride, or diacylglycerol (DAG), is a glyceride consisting of two fatty acid chains covalently bonded to a glycerol molecule through ester linkages. Two possible forms exist, 1,2-diacylglycerols and 1,3-diacylglycerols. Diglycerides are natural components of food fats, though minor in comparison to triglycerides. DAGs can act as surfactants and are commonly used as emulsifiers in processed foods. DAG-enriched oil has been investigated extensively as a fat substitute due to its ability to suppress the accumulation of body fat; with total annual sales of approximately USD 200 million in Japan since its introduction in the late 1990s till 2009.

References

  1. 1 2 3 4 5 "Overview of Lipid Metabolism". Merck Manuals Professional Edition. Retrieved 2016-11-01.
  2. 1 2 3 "Hydrolysis – Chemistry Encyclopedia – structure, reaction, water, proteins, examples, salt, molecule". chemistryexplained.com. Retrieved 2016-11-01.
  3. 1 2 Freifelder D (1987). Molecular biology (2nd ed.). Boston: Jones and Bartlett. ISBN   978-0-86720-069-0.
  4. ↑ Baynes D (2014). Medical Biochemistry. Saunders, Elsevier Limited. pp. 121–122. ISBN   978-1-4557-4580-7.
  5. ↑ Arrese EL, Soulages JL (2010). "Insect fat body: energy, metabolism, and regulation". Annual Review of Entomology. 55: 207–25. doi:10.1146/annurev-ento-112408-085356. PMC   3075550 . PMID   19725772.
  6. 1 2 3 4 5 6 7 8 Lehninger AL, Nelson DL, Cox MM (2000). Lehninger Principles of Biochemistry (3rd ed.). New York: Worth Publishers. ISBN   978-1-57259-931-4.
  7. ↑ Ophardt CE (2013). "Lipid Metabolism Summary". Virtual Chembook. Elmhurst College.
  8. ↑ Wedding RT (May 1972). "Reviewed Work: Plant Lipid Biochemistry". The New Phytologist . 71 (3): 547–548. JSTOR   2430826?.
  9. 1 2 Jo Y, Okazaki H, Moon YA, Zhao T (2016). "Regulation of Lipid Metabolism and Beyond". International Journal of Endocrinology. 2016: 5415767. doi: 10.1155/2016/5415767 . PMC   4880713 . PMID   27293434.
  10. ↑ Pelley JW (2012). Elsevier's Integrated Review Biochemistry (2nd ed.). Philadelphia: Elsevier/Mosby. ISBN   978-0-323-07446-9.
  11. ↑ Voet D, Voet JG, Pratt CW (2013). Fundamentals of Biochemistry: Life at the Molecular Level (Fourth ed.). Hoboken, NJ: Wiley. ISBN   978-0-470-54784-7. OCLC   738349533.
  12. ↑ Harris JR (2009). Cholesterol binding and cholesterol transport proteins: structure and function in health and disease. Dordrecht: Springer. ISBN   978-90-481-8621-1.
  13. ↑ Mechanism of Storage and Synthesis of Fatty Acids and Triglycerides in White Adipocytes | Physiology and Physiopathology of Adipose Tissue pp 101–121 | DOI: 10.1007/978-2-8178-0343-2_8
  14. ↑ Feingold KR, Grunfeld C (2000). "Introduction to Lipids and Lipoproteins". In De Groot LJ, Chrousos G, Dungan K, Feingold KR, Grossman A, Hershman JM, Koch C, Korbonits M, McLachlan R (eds.). Endotext. South Dartmouth (MA): MDText.com, Inc. PMID   26247089.
  15. 1 2 3 "Fatty Acid beta-Oxidation – AOCS Lipid Library". lipidlibrary.aocs.org. Archived from the original on 2019-01-21. Retrieved 2017-11-28.
  16. 1 2 Scheffler IE (2008). Mitochondria (2nd ed.). Hoboken, N.J.: Wiley-Liss. ISBN   978-0-470-04073-7.
  17. ↑ Choe SS, Huh JY, Hwang IJ, Kim JI, Kim JB (2016-04-13). "Adipose Tissue Remodeling: Its Role in Energy Metabolism and Metabolic Disorders". Frontiers in Endocrinology. 7: 30. doi: 10.3389/fendo.2016.00030 . PMC   4829583 . PMID   27148161.
  18. 1 2 Gault CR, Obeid LM, Hannun YA (2010). "An Overview of Sphingolipid Metabolism: From Synthesis to Breakdown". Sphingolipids as Signaling and Regulatory Molecules. Advances in Experimental Medicine and Biology. Vol. 688. pp. 1–23. doi:10.1007/978-1-4419-6741-1_1. ISBN   978-1-4419-6740-4. PMC   3069696 . PMID   20919643.
  19. 1 2 Lok CM, Ward JP, van Dorp DA (March 1976). "The synthesis of chiral glycerides starting from D- and L-serine". Chemistry and Physics of Lipids. 16 (2): 115–22. doi:10.1016/0009-3084(76)90003-7. PMID   1269065.
  20. ↑ Sokolova, E. I.; Perova, N. V. (2004-07-01). "Hormonal Regulation of Lipid Metabolism in Healthy Subjects with or without Obesity". Human Physiology. 30 (4): 441–444. doi:10.1023/B:HUMP.0000036339.26918.92. ISSN   1608-3164.
  21. 1 2 3 4 5 Zhang, Dengke; Wei, Yanghui; Huang, Qingnan; Chen, Yong; Zeng, Kai; Yang, Weiqin; Chen, Juan; Chen, Jiawei (January 2022). "Important Hormones Regulating Lipid Metabolism". Molecules. 27 (20): 7052. doi: 10.3390/molecules27207052 . ISSN   1420-3049. PMC   9607181 . PMID   36296646.
  22. 1 2 "Lipid Metabolism Disorders". MedlinePlus . Retrieved 2016-11-20.
  23. ↑ O'Malley K (1984). Clinical Pharmacology and Drug treatment in the elderly. Edinburgh; New York: Churchill Livingstone. ISBN   978-0-443-02297-5.
  24. 1 2 "Disorders of Lipid Metabolism". Merck Manuals Consumer Version. Retrieved 2016-11-20.
  25. 1 2 3 Alberts B, Johnson A, Lewis J, Raff M, Roberts K, Walter P (2002). "The Lipid Bilayer". Molecular Biology of the Cell (4th ed.). Garland Science. ISBN   978-0-8153-3218-3.
  26. 1 2 Incardona JP, Eaton S (April 2000). "Cholesterol in signal transduction". Current Opinion in Cell Biology. 12 (2): 193–203. doi:10.1016/s0955-0674(99)00076-9. PMID   10712926.
  27. ↑ Russell DW (2003). "The enzymes, regulation, and genetics of bile acid synthesis". Annual Review of Biochemistry. 72: 137–74. doi:10.1146/annurev.biochem.72.121801.161712. PMID   12543708.
  28. ↑ Williams KI, Higgs GA (October 1988). "Eicosanoids and Inflammation". The Journal of Pathology. 156 (2): 101–110. doi: 10.1002/path.1711560204 . PMID   3058912. S2CID   34803631.

Lipid+metabolism at the U.S. National Library of Medicine Medical Subject Headings (MeSH)

This page is based on this Wikipedia article
Text is available under the CC BY-SA 4.0 license; additional terms may apply.
Images, videos and audio are available under their respective licenses.